메뉴 건너뛰기
OncoImmunology
Volumn 5, Issue 2, 2016, Pages
Immunotherapy for cancer in the central nervous system: Current and future directions
Author keywords

Brain metastases; glioblastoma; glioma; IDO; T cell therapy; vaccination
Indexed keywords

EID: 84959378533     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1082027     Document Type: Article
Times cited : (71)
References (110)
  • 4
    • 0002802349 scopus 로고
    • On the transplantation of the rat sarcoma in adult heterogenous animals
    • Y.Shirai. On the transplantation of the rat sarcoma in adult heterogenous animals. Jap Med World 1921; 1:14-5
    • (1921) Jap Med World , vol.1 , pp. 14-15
    • Shirai, Y.1
  • 5
    • 33748743268 scopus 로고    scopus 로고
    • CNS immune privilege: hiding in plain sight
    • 16972896
    • M.J.Carson, J.M.Doose, B.Melchior, C.D.Schmid, C.C.Ploix. CNS immune privilege: hiding in plain sight. Immunological Rev 2006; 213:48-65; PMID:16972896; http://dx.doi.org/10.1111/j.1600-065X.2006.00441.x
    • (2006) Immunological Rev , vol.213 , pp. 48-65
    • Carson, M.J.1    Doose, J.M.2    Melchior, B.3    Schmid, C.D.4    Ploix, C.C.5
  • 6
    • 66449130960 scopus 로고    scopus 로고
    • Regulation of innate immune responses in the brain
    • 19461673
    • S.Rivest. Regulation of innate immune responses in the brain. Nature Rev Immunol 2009; 9:429-39; PMID:19461673; http://dx.doi.org/10.1038/nri2565
    • (2009) Nature Rev Immunol , vol.9 , pp. 429-439
    • Rivest, S.1
  • 7
    • 33646533333 scopus 로고    scopus 로고
    • Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis
    • 16541395
    • A.Farin, S.O.Suzuki, M.Weiker, J.E.Goldman, J.N.Bruce, P.Canoll. Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 2006; 53:799-808; PMID:16541395; http://dx.doi.org/10.1002/glia.20334
    • (2006) Glia , vol.53 , pp. 799-808
    • Farin, A.1    Suzuki, S.O.2    Weiker, M.3    Goldman, J.E.4    Bruce, J.N.5    Canoll, P.6
  • 8
    • 84903183157 scopus 로고    scopus 로고
    • Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells
    • 24943270
    • S.Watkins, S.Robel, I.F.Kimbrough, S.M.Robert, G.Ellis-Davies, H.Sontheimer. Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nature Communications 2014; 5:4196; PMID:24943270; http://dx.doi.org/10.1038/ncomms5196
    • (2014) Nature Communications , vol.5 , pp. 4196
    • Watkins, S.1    Robel, S.2    Kimbrough, I.F.3    Robert, S.M.4    Ellis-Davies, G.5    Sontheimer, H.6
  • 9
    • 79952711945 scopus 로고    scopus 로고
    • Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
    • 21135147
    • R.M.Prins, H.Soto, V.Konkankit, S.K.Odesa, A.Eskin, W.H.Yong, S.F.Nelson, L.M.Liau. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res 2011; 17:1603-15; PMID:21135147; http://dx.doi.org/10.1158/1078-0432.CCR-10-2563
    • (2011) Clin Cancer Res , vol.17 , pp. 1603-1615
    • Prins, R.M.1    Soto, H.2    Konkankit, V.3    Odesa, S.K.4    Eskin, A.5    Yong, W.H.6    Nelson, S.F.7    Liau, L.M.8
  • 10
    • 84906673966 scopus 로고    scopus 로고
    • MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma
    • 25114226
    • B.J.Gill, D.J.Pisapia, H.R.Malone, H.Goldstein, L.Lei, A.Sonabend, J.Yun, J.Samanamud, J.S.Sims, M.Banu et al. MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma. Proc Natl Acad Sci U S A 2014; 111:12550-5; PMID:25114226; http://dx.doi.org/10.1073/pnas.1405839111
    • (2014) Proc Natl Acad Sci U S A , vol.111 , pp. 12550-12555
    • Gill, B.J.1    Pisapia, D.J.2    Malone, H.R.3    Goldstein, H.4    Lei, L.5    Sonabend, A.6    Yun, J.7    Samanamud, J.8    Sims, J.S.9    Banu, M.10
  • 11
    • 84878865462 scopus 로고    scopus 로고
    • Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas
    • discussion 8, 9, 23426156
    • K.Mitsuka, T.Kawataki, E.Satoh, T.Asahara, T.Horikoshi, H.Kinouchi. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas. Neurosurgery 2013; 72:1031-8; discussion 8–9; PMID:23426156; http://dx.doi.org/10.1227/NEU.0b013e31828cf945
    • (2013) Neurosurgery , vol.72 , pp. 1038
    • Mitsuka, K.1    Kawataki, T.2    Satoh, E.3    Asahara, T.4    Horikoshi, T.5    Kinouchi, H.6
  • 18
    • 34247502076 scopus 로고    scopus 로고
    • Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function
    • 17404100
    • P.E.Fecci, H.Ochiai, D.A.Mitchell, P.M.Grossi, A.E.Sweeney, G.E.Archer, T.Cummings, J.P.Allison, D.D.Bigner, J.H.Sampson. Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function. Clin Cancer Res 2007; 13:2158-67; PMID:17404100; http://dx.doi.org/10.1158/1078-0432.CCR-06-2070
    • (2007) Clin Cancer Res , vol.13 , pp. 2158-2167
    • Fecci, P.E.1    Ochiai, H.2    Mitchell, D.A.3    Grossi, P.M.4    Sweeney, A.E.5    Archer, G.E.6    Cummings, T.7    Allison, J.P.8    Bigner, D.D.9    Sampson, J.H.10
  • 20
    • 68149164402 scopus 로고    scopus 로고
    • Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen cross-presented on stromal cells
    • 19592642
    • D.L.Thomas, M.Kim, N.A.Bowerman, S.Narayanan, D.M.Kranz, H.Schreiber, E.J.Roy. Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen cross-presented on stromal cells. J Immunol 2009; 183:1828-37; PMID:19592642; http://dx.doi.org/10.4049/jimmunol.0802322
    • (2009) J Immunol , vol.183 , pp. 1828-1837
    • Thomas, D.L.1    Kim, M.2    Bowerman, N.A.3    Narayanan, S.4    Kranz, D.M.5    Schreiber, H.6    Roy, E.J.7
  • 21
    • 84892907751 scopus 로고    scopus 로고
    • Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer
    • 24455752
    • D.C.Binder, B.Engels, A.Arina, P.Yu, J.M.Slauch, Y.X.Fu, T.Karrison, B.Burnette, C.Idel, M.Zhao et al. Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer. Cancer Immunol Res 2013; 1:123-33; PMID:24455752; http://dx.doi.org/10.1158/2326-6066.CIR-13-0058
    • (2013) Cancer Immunol Res , vol.1 , pp. 123-133
    • Binder, D.C.1    Engels, B.2    Arina, A.3    Yu, P.4    Slauch, J.M.5    Fu, Y.X.6    Karrison, T.7    Burnette, B.8    Idel, C.9    Zhao, M.10
  • 23
    • 55549130240 scopus 로고    scopus 로고
    • Specificity in cancer immunotherapy
    • 18684640
    • A.Schietinger, M.Philip, H.Schreiber. Specificity in cancer immunotherapy. Semin Immunol 2008; 20:276-85; PMID:18684640; http://dx.doi.org/10.1016/j.smim.2008.07.001
    • (2008) Semin Immunol , vol.20 , pp. 276-285
    • Schietinger, A.1    Philip, M.2    Schreiber, H.3
  • 24
    • 0019973322 scopus 로고
    • Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. I. Identification by monoclonal anti-melanoma and anti-glioma antibodies
    • 6181646
    • S.Carrel, N.de Tribolet, J.P.Mach. Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. I. Identification by monoclonal anti-melanoma and anti-glioma antibodies. Acta Neuropathol 1982; 57:158-64; PMID:6181646; http://dx.doi.org/10.1007/BF00685384
    • (1982) Acta Neuropathol , vol.57 , pp. 158-164
    • Carrel, S.1    de Tribolet, N.2    Mach, J.P.3
  • 27
    • 79951978155 scopus 로고    scopus 로고
    • Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {α}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
    • 21149657
    • H.Okada, P.Kalinski, R.Ueda, A.Hoji, G.Kohanbash, T.E.Donegan, A.H.Mintz, J.A.Engh, D.L.Bartlett, C.K.Brown et al. Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {α}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. J Clin Oncol 2011; 29:330-6; PMID:21149657; http://dx.doi.org/10.1200/JCO.2010.30.7744
    • (2011) J Clin Oncol , vol.29 , pp. 330-336
    • Okada, H.1    Kalinski, P.2    Ueda, R.3    Hoji, A.4    Kohanbash, G.5    Donegan, T.E.6    Mintz, A.H.7    Engh, J.A.8    Bartlett, D.L.9    Brown, C.K.10
  • 28
    • 0028947046 scopus 로고
    • A unique tumor antigen produced by a single amino acid substitution
    • 7600302
    • P.A.Monach, S.C.Meredith, C.T.Siegel, H.Schreiber. A unique tumor antigen produced by a single amino acid substitution. Immunity 1995; 2:45-59; PMID:7600302; http://dx.doi.org/10.1016/1074-7613(95)90078-0
    • (1995) Immunity , vol.2 , pp. 45-59
    • Monach, P.A.1    Meredith, S.C.2    Siegel, C.T.3    Schreiber, H.4
  • 29
  • 30
    • 14644412873 scopus 로고    scopus 로고
    • Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients
    • 15746047
    • A.B.Heimberger, R.Hlatky, D.Suki, D.Yang, J.Weinberg, M.Gilbert, R.Sawaya, K.Aldape. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clin Cancer Res 2005; 11:1462-6; PMID:15746047; http://dx.doi.org/10.1158/1078-0432.CCR-04-1737
    • (2005) Clin Cancer Res , vol.11 , pp. 1462-1466
    • Heimberger, A.B.1    Hlatky, R.2    Suki, D.3    Yang, D.4    Weinberg, J.5    Gilbert, M.6    Sawaya, R.7    Aldape, K.8
  • 32
    • 78149254368 scopus 로고    scopus 로고
    • Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma
    • 20921459
    • J.H.Sampson, A.B.Heimberger, G.E.Archer, K.D.Aldape, A.H.Friedman, H.S.Friedman, M.R.Gilbert, J.E.Herndon2nd, R.E.McLendon, D.A.Mitchell et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J Clin Oncol 2010; 28:4722-9; PMID:20921459; http://dx.doi.org/10.1200/JCO.2010.28.6963
    • (2010) J Clin Oncol , vol.28 , pp. 4722-4729
    • Sampson, J.H.1    Heimberger, A.B.2    Archer, G.E.3    Aldape, K.D.4    Friedman, A.H.5    Friedman, H.S.6    Gilbert, M.R.7    Herndon, J.E.8    McLendon, R.E.9    Mitchell, D.A.10
  • 34
    • 79955784386 scopus 로고    scopus 로고
    • Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
    • 21149254
    • J.H.Sampson, K.D.Aldape, G.E.Archer, A.Coan, A.Desjardins, A.H.Friedman, H.S.Friedman, M.R.Gilbert, J.E.Herndon, R.E.McLendon et al. Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma. Neuro-Oncol 2011; 13:324-33; PMID:21149254; http://dx.doi.org/10.1093/neuonc/noq157
    • (2011) Neuro-Oncol , vol.13 , pp. 324-333
    • Sampson, J.H.1    Aldape, K.D.2    Archer, G.E.3    Coan, A.4    Desjardins, A.5    Friedman, A.H.6    Friedman, H.S.7    Gilbert, M.R.8    Herndon, J.E.9    McLendon, R.E.10
  • 35
    • 80051605627 scopus 로고    scopus 로고
    • Immunotherapy for glioblastoma: the devil is in the details
    • author reply -6, 21709193
    • M.S.Lesniak. Immunotherapy for glioblastoma: the devil is in the details. J Clin Oncol 2011; 29:3105; author reply -6; PMID:21709193; http://dx.doi.org/10.1200/JCO.2011.34.9019; http://dx.doi.org/10.1093/neuonc/nou348
    • (2011) J Clin Oncol , vol.29 , pp. 3105
    • Lesniak, M.S.1
  • 38
    • 0035070198 scopus 로고    scopus 로고
    • CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin
    • 11290339
    • S.Basu, R.J.Binder, T.Ramalingam, P.K.Srivastava. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001; 14:303-13; PMID:11290339; http://dx.doi.org/10.1016/S1074-7613(01)00111-X
    • (2001) Immunity , vol.14 , pp. 303-313
    • Basu, S.1    Binder, R.J.2    Ramalingam, T.3    Srivastava, P.K.4
  • 41
    • 84880276438 scopus 로고    scopus 로고
    • Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
    • 23644516
    • P.F.Robbins, Y.C.Lu, M.El-Gamil, Y.F.Li, C.Gross, J.Gartner, J.C.Lin, J.K.Teer, P.Cliften, E.Tycksen et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med 2013; 19:747-52; PMID:23644516; http://dx.doi.org/10.1038/nm.3161
    • (2013) Nat Med , vol.19 , pp. 747-752
    • Robbins, P.F.1    Lu, Y.C.2    El-Gamil, M.3    Li, Y.F.4    Gross, C.5    Gartner, J.6    Lin, J.C.7    Teer, J.K.8    Cliften, P.9    Tycksen, E.10
  • 43
    • 84896711067 scopus 로고    scopus 로고
    • High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies
    • 24563823
    • D.C.Binder, H.Schreiber. High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies. Oncoimmunology 2013; 2:e26704; PMID:24563823; http://dx.doi.org/10.4161/onci.26704
    • (2013) Oncoimmunology , vol.2 , pp. 26704
    • Binder, D.C.1    Schreiber, H.2
  • 44
    • 84892932892 scopus 로고    scopus 로고
    • Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors–Letter
    • 24408925
    • D.C.Binder, H.Schreiber. Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors–Letter. Cancer Res 2014; 74:632; PMID:24408925; http://dx.doi.org/10.1158/0008-5472.CAN-13-2216
    • (2014) Cancer Res , vol.74 , pp. 632
    • Binder, D.C.1    Schreiber, H.2
  • 45
    • 0029947568 scopus 로고    scopus 로고
    • Enhancement of antitumor immunity by CTLA-4 blockade
    • 8596936
    • D.R.Leach, M.F.Krummel, J.P.Allison. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996; 271:1734-6; PMID:8596936; http://dx.doi.org/10.1126/science.271.5256.1734
    • (1996) Science , vol.271 , pp. 1734-1736
    • Leach, D.R.1    Krummel, M.F.2    Allison, J.P.3
  • 46
    • 0029120245 scopus 로고
    • CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
    • 7543139
    • M.F.Krummel, J.P.Allison. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995; 182:459-65; PMID:7543139; http://dx.doi.org/10.1084/jem.182.2.459
    • (1995) J Exp Med , vol.182 , pp. 459-465
    • Krummel, M.F.1    Allison, J.P.2
  • 51
    • 84859128199 scopus 로고    scopus 로고
    • Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of imune escape
    • J.M.Taube, R.A.Anders, G.D.Young, H.Xu, R.Sharma, T.L.McMiller, S.Chen, A.P.Klein, D.M.Pardoll, S.L.Topalian et al. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of imune escape. Sci Transl Med 2012; 4:127ra37; PMID:22461641; http://dx.doi.org/10.1126/scitranslmed.3003689
    • (2012) Sci Transl Med , vol.4 , pp. 127
    • Taube, J.M.1    Anders, R.A.2    Young, G.D.3    Xu, H.4    Sharma, R.5    McMiller, T.L.6    Chen, S.7    Klein, A.P.8    Pardoll, D.M.9    Topalian, S.L.10
  • 55
    • 77749279776 scopus 로고    scopus 로고
    • PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
    • 20160101
    • M.A.Curran, W.Montalvo, H.Yagita, J.P.Allison. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci U S A 2010; 107:4275-80; PMID:20160101; http://dx.doi.org/10.1073/pnas.0915174107
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 4275-4280
    • Curran, M.A.1    Montalvo, W.2    Yagita, H.3    Allison, J.P.4
  • 58
    • 84904061991 scopus 로고    scopus 로고
    • Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors
    • 24691018
    • D.A.Wainwright, A.L.Chang, M.Dey, I.V.Balyasnikova, C.K.Kim, A.Tobias, Y.Cheng, J.W.Kim, J.Qiao, L.Zhang et al. Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors. Clin Cancer Res 2014; 20:5290-301; PMID:24691018; http://dx.doi.org/10.1158/1078-0432.CCR-14-0514
    • (2014) Clin Cancer Res , vol.20 , pp. 5290-5301
    • Wainwright, D.A.1    Chang, A.L.2    Dey, M.3    Balyasnikova, I.V.4    Kim, C.K.5    Tobias, A.6    Cheng, Y.7    Kim, J.W.8    Qiao, J.9    Zhang, L.10
  • 59
    • 84863115998 scopus 로고    scopus 로고
    • Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape
    • 22186141
    • S.R.Woo, M.E.Turnis, M.V.Goldberg, J.Bankoti, M.Selby, C.J.Nirschl, M.L.Bettini, D.M.Gravano, P.Vogel, C.L.Liu et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res 2012; 72:917-27; PMID:22186141; http://dx.doi.org/10.1158/0008-5472.CAN-11-1620
    • (2012) Cancer Res , vol.72 , pp. 917-927
    • Woo, S.R.1    Turnis, M.E.2    Goldberg, M.V.3    Bankoti, J.4    Selby, M.5    Nirschl, C.J.6    Bettini, M.L.7    Gravano, D.M.8    Vogel, P.9    Liu, C.L.10
  • 60
    • 77957744369 scopus 로고    scopus 로고
    • Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
    • 20819927
    • K.Sakuishi, L.Apetoh, J.M.Sullivan, B.R.Blazar, V.K.Kuchroo, A.C.Anderson. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010; 207:2187-94; PMID:20819927; http://dx.doi.org/10.1084/jem.20100643
    • (2010) J Exp Med , vol.207 , pp. 2187-2194
    • Sakuishi, K.1    Apetoh, L.2    Sullivan, J.M.3    Blazar, B.R.4    Kuchroo, V.K.5    Anderson, A.C.6
  • 61
    • 84897940775 scopus 로고    scopus 로고
    • Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
    • 24687957
    • X.Fan, S.A.Quezada, M.A.Sepulveda, P.Sharma, J.P.Allison. Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy. J Exp Med 2014; 211:715-25; PMID:24687957; http://dx.doi.org/10.1084/jem.20130590
    • (2014) J Exp Med , vol.211 , pp. 715-725
    • Fan, X.1    Quezada, S.A.2    Sepulveda, M.A.3    Sharma, P.4    Allison, J.P.5
  • 62
    • 84904207094 scopus 로고    scopus 로고
    • Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model
    • 25013914
    • Z.Belcaid, J.A.Phallen, J.Zeng, A.P.See, D.Mathios, C.Gottschalk, S.Nicholas, M.Kellett, J.Ruzevick, C.Jackson et al. Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model. PLoS One 2014; 9:e101764; PMID:25013914; http://dx.doi.org/10.1371/journal.pone.0101764
    • (2014) PLoS One , vol.9 , pp. 101764
    • Belcaid, Z.1    Phallen, J.A.2    Zeng, J.3    See, A.P.4    Mathios, D.5    Gottschalk, C.6    Nicholas, S.7    Kellett, M.8    Ruzevick, J.9    Jackson, C.10
  • 63
    • 84928759208 scopus 로고    scopus 로고
    • Adoptive cell transfer as personalized immunotherapy for human cancer
    • 25838374
    • S.A.Rosenberg, N.P.Restifo. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015; 348:62-8; PMID:25838374; http://dx.doi.org/10.1126/science.aaa4967
    • (2015) Science , vol.348 , pp. 62-68
    • Rosenberg, S.A.1    Restifo, N.P.2
  • 67
    • 84903621256 scopus 로고    scopus 로고
    • Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma
    • 24795429
    • A.Schuessler, C.Smith, L.Beagley, G.M.Boyle, S.Rehan, K.Matthews, L.Jones, T.Crough, V.Dasari, K.Klein et al. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. Cancer Res 2014; 74:3466-76; PMID:24795429; http://dx.doi.org/10.1158/0008-5472.CAN-14-0296
    • (2014) Cancer Res , vol.74 , pp. 3466-3476
    • Schuessler, A.1    Smith, C.2    Beagley, L.3    Boyle, G.M.4    Rehan, S.5    Matthews, K.6    Jones, L.7    Crough, T.8    Dasari, V.9    Klein, K.10
  • 68
    • 84901008742 scopus 로고    scopus 로고
    • Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells
    • 24658154
    • S.K.Nair, G.De Leon, D.Boczkowski, R.Schmittling, W.Xie, J.Staats, R.Liu, L.A.Johnson, K.Weinhold, G.E.Archer et al. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells. Clin Cancer Res 2014; 20:2684-94; PMID:24658154; http://dx.doi.org/10.1158/1078-0432.CCR-13-3268
    • (2014) Clin Cancer Res , vol.20 , pp. 2684-2694
    • Nair, S.K.1    De Leon, G.2    Boczkowski, D.3    Schmittling, R.4    Xie, W.5    Staats, J.6    Liu, R.7    Johnson, L.A.8    Weinhold, K.9    Archer, G.E.10
  • 69
    • 74549196076 scopus 로고    scopus 로고
    • HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors
    • 20068073
    • N.Ahmed, V.S.Salsman, Y.Kew, D.Shaffer, S.Powell, Y.J.Zhang, R.G.Grossman, H.E.Heslop, S.Gottschalk. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors. Clin Cancer Res 2010; 16:474-85; PMID:20068073; http://dx.doi.org/10.1158/1078-0432.CCR-09-1322
    • (2010) Clin Cancer Res , vol.16 , pp. 474-485
    • Ahmed, N.1    Salsman, V.S.2    Kew, Y.3    Shaffer, D.4    Powell, S.5    Zhang, Y.J.6    Grossman, R.G.7    Heslop, H.E.8    Gottschalk, S.9
  • 70
    • 84923078274 scopus 로고    scopus 로고
    • Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma
    • 25696001
    • L.A.Johnson, J.Scholler, T.Ohkuri, A.Kosaka, P.R.Patel, S.E.McGettigan, A.K.Nace, T.Dentchev, P.Thekkat, A.Loew et al. Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma. Sci Transl Med 2015; 7:275ra22; PMID:25696001; http://dx.doi.org/10.1126/scitranslmed.aaa4963
    • (2015) Sci Transl Med , vol.7 , pp. 275
    • Johnson, L.A.1    Scholler, J.2    Ohkuri, T.3    Kosaka, A.4    Patel, P.R.5    McGettigan, S.E.6    Nace, A.K.7    Dentchev, T.8    Thekkat, P.9    Loew, A.10
  • 71
    • 70149113060 scopus 로고    scopus 로고
    • Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
    • 19349616
    • Y.Lee, S.L.Auh, Y.Wang, B.Burnette, Y.Wang, Y.Meng, M.Beckett, R.Sharma, R.Chin, T.Tu et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009; 114:589-95; PMID:19349616; http://dx.doi.org/10.1182/blood-2009-02-206870
    • (2009) Blood , vol.114 , pp. 589-595
    • Lee, Y.1    Auh, S.L.2    Wang, Y.3    Burnette, B.4    Wang, Y.5    Meng, Y.6    Beckett, M.7    Sharma, R.8    Chin, R.9    Tu, T.10
  • 72
    • 84912128872 scopus 로고    scopus 로고
    • STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
    • 25517616
    • L.Deng, H.Liang, M.Xu, X.Yang, B.Burnette, A.Arina, X.D.Li, H.Mauceri, M.Beckett, T.Darga et al. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity 2014; 41:843-52; PMID:25517616; http://dx.doi.org/10.1016/j.immuni.2014.10.019
    • (2014) Immunity , vol.41 , pp. 843-852
    • Deng, L.1    Liang, H.2    Xu, M.3    Yang, X.4    Burnette, B.5    Arina, A.6    Li, X.D.7    Mauceri, H.8    Beckett, M.9    Darga, T.10
  • 73
    • 77954238185 scopus 로고    scopus 로고
    • Role of type 1 IFNs in antiglioma immunosurveillance–using mouse studies to guide examination of novel prognostic markers in humans
    • 20472682
    • M.Fujita, M.E.Scheurer, S.A.Decker, H.A.McDonald, G.Kohanbash, E.R.Kastenhuber, H.Kato, M.L.Bondy, J.R.Ohlfest, H.Okada. Role of type 1 IFNs in antiglioma immunosurveillance–using mouse studies to guide examination of novel prognostic markers in humans. Clin Cancer Res 2010; 16:3409-19; PMID:20472682; http://dx.doi.org/10.1158/1078-0432.CCR-10-0644
    • (2010) Clin Cancer Res , vol.16 , pp. 3409-3419
    • Fujita, M.1    Scheurer, M.E.2    Decker, S.A.3    McDonald, H.A.4    Kohanbash, G.5    Kastenhuber, E.R.6    Kato, H.7    Bondy, M.L.8    Ohlfest, J.R.9    Okada, H.10
  • 74
    • 84964698449 scopus 로고    scopus 로고
    • STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment
    • 25300859
    • T.Ohkuri, A.Ghosh, A.Kosaka, J.Zhu, M.Ikeura, M.David, S.C.Watkins, S.N.Sarkar, H.Okada. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment. Cancer Immunol Res 2014; 2:1199-208; PMID:25300859; http://dx.doi.org/10.1158/2326-6066.CIR-14-0099
    • (2014) Cancer Immunol Res , vol.2 , pp. 1199-1208
    • Ohkuri, T.1    Ghosh, A.2    Kosaka, A.3    Zhu, J.4    Ikeura, M.5    David, M.6    Watkins, S.C.7    Sarkar, S.N.8    Okada, H.9
  • 75
    • 84877328940 scopus 로고    scopus 로고
    • Integration of epidemiology, immunobiology, and translational research for brain tumors
    • 23651189
    • H.Okada, M.E.Scheurer, S.N.Sarkar, M.L.Bondy. Integration of epidemiology, immunobiology, and translational research for brain tumors. Ann N Y Acad Sci 2013; 1284:17-23; PMID:23651189; http://dx.doi.org/10.1111/nyas.12115
    • (2013) Ann N Y Acad Sci , vol.1284 , pp. 17-23
    • Okada, H.1    Scheurer, M.E.2    Sarkar, S.N.3    Bondy, M.L.4
  • 77
    • 84893876109 scopus 로고    scopus 로고
    • Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
    • 24382348
    • L.Deng, H.Liang, B.Burnette, M.Beckett, T.Darga, R.R.Weichselbaum, Y.X.Fu. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest 2014; 124:687-95; PMID:24382348; http://dx.doi.org/10.1172/JCI67313
    • (2014) J Clin Invest , vol.124 , pp. 687-695
    • Deng, L.1    Liang, H.2    Burnette, B.3    Beckett, M.4    Darga, T.5    Weichselbaum, R.R.6    Fu, Y.X.7
  • 78
    • 12244252335 scopus 로고    scopus 로고
    • Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer
    • 15701862
    • S.Demaria, N.Kawashima, A.M.Yang, M.L.Devitt, J.S.Babb, J.P.Allison, S.C.Formenti. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res 2005; 11:728-34; PMID:15701862
    • (2005) Clin Cancer Res , vol.11 , pp. 728-734
    • Demaria, S.1    Kawashima, N.2    Yang, A.M.3    Devitt, M.L.4    Babb, J.S.5    Allison, J.P.6    Formenti, S.C.7
  • 81
    • 51349149926 scopus 로고    scopus 로고
    • Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice
    • 18723683
    • A.Bai, E.Higham, H.N.Eisen, K.D.Wittrup, J.Chen. Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice. Proc Natl Acad Sci U S A 2008; 105:13003-8; PMID:18723683; http://dx.doi.org/10.1073/pnas.0805599105
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 13003-13008
    • Bai, A.1    Higham, E.2    Eisen, H.N.3    Wittrup, K.D.4    Chen, J.5
  • 82
    • 84897934799 scopus 로고    scopus 로고
    • TLR Agonists for Cancer Immunotherapy: Tipping the Balance between the Immune Stimulatory and Inhibitory Effects
    • 24624132
    • H.Lu. TLR Agonists for Cancer Immunotherapy: Tipping the Balance between the Immune Stimulatory and Inhibitory Effects. Front Immunol 2014; 5:83; PMID:24624132; http://dx.doi.org/10.3389/fimmu.2014.00083
    • (2014) Front Immunol , vol.5 , pp. 83
    • Lu, H.1
  • 83
    • 84879104519 scopus 로고    scopus 로고
    • Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors
    • 23633484
    • J.Duraiswamy, K.M.Kaluza, G.J.Freeman, G.Coukos. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer Res 2013; 73:3591-603; PMID:23633484; http://dx.doi.org/10.1158/0008-5472.CAN-12-4100
    • (2013) Cancer Res , vol.73 , pp. 3591-3603
    • Duraiswamy, J.1    Kaluza, K.M.2    Freeman, G.J.3    Coukos, G.4
  • 85
    • 33947593164 scopus 로고    scopus 로고
    • Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells
    • 17164341
    • A.Curti, S.Pandolfi, B.Valzasina, M.Aluigi, A.Isidori, E.Ferri, V.Salvestrini, G.Bonanno, S.Rutella, I.Durelli et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood 2007; 109:2871-7; PMID:17164341; http://dx.doi.org/10.1182/blood-2006-07-036863
    • (2007) Blood , vol.109 , pp. 2871-2877
    • Curti, A.1    Pandolfi, S.2    Valzasina, B.3    Aluigi, M.4    Isidori, A.5    Ferri, E.6    Salvestrini, V.7    Bonanno, G.8    Rutella, S.9    Durelli, I.10
  • 86
    • 77955665451 scopus 로고    scopus 로고
    • Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions
    • 20493562
    • T.Avril, S.Saikali, E.Vauleon, A.Jary, A.Hamlat, M.De Tayrac, J.Mosser, V.Quillien. Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions. J Neuroimmunol 2010; 225:22-33; PMID:20493562; http://dx.doi.org/10.1016/j.jneuroim.2010.04.003
    • (2010) J Neuroimmunol , vol.225 , pp. 22-33
    • Avril, T.1    Saikali, S.2    Vauleon, E.3    Jary, A.4    Hamlat, A.5    De Tayrac, M.6    Mosser, J.7    Quillien, V.8
  • 87
    • 77955279163 scopus 로고    scopus 로고
    • Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation
    • A.D.Cohen, D.A.Schaer, C.Liu, Y.Li, D.Hirschhorn-Cymmerman, S.C.Kim, A.Diab, G.Rizzuto, F.Duan, M.A.Perales et al. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation. PLoS One 2010; 5:e10436; PMID:20454651; http://dx.doi.org/10.1371/journal.pone.0010436
    • (2010) PLoS One , vol.5 , pp. 10436
    • Cohen, A.D.1    Schaer, D.A.2    Liu, C.3    Li, Y.4    Hirschhorn-Cymmerman, D.5    Kim, S.C.6    Diab, A.7    Rizzuto, G.8    Duan, F.9    Perales, M.A.10
  • 88
    • 77954899030 scopus 로고    scopus 로고
    • Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
    • 20516446
    • J.R.`Brahmer, C.G.Drake, I.Wollner, J.D.Powderly, J.Picus, W.H.Sharfman, E.Stankevich, A.Pons, T.M.Salay, T.L.McMiller et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 2010; 28:3167-75; PMID:20516446; http://dx.doi.org/10.1200/JCO.2009.26.7609
    • (2010) J Clin Oncol , vol.28 , pp. 3167-3175
    • Brahmer, J.R.1    Drake, C.G.2    Wollner, I.3    Powderly, J.D.4    Picus, J.5    Sharfman, W.H.6    Stankevich, E.7    Pons, A.8    Salay, T.M.9    McMiller, T.L.10
  • 89
    • 79960003585 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
    • 21636707
    • B.Raychaudhuri, P.Rayman, J.Ireland, J.Ko, B.Rini, E.C.Borden, J.Garcia, M.A.Vogelbaum, J.Finke. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol 2011; 13:591-9; PMID:21636707; http://dx.doi.org/10.1093/neuonc/nor042
    • (2011) Neuro Oncol , vol.13 , pp. 591-599
    • Raychaudhuri, B.1    Rayman, P.2    Ireland, J.3    Ko, J.4    Rini, B.5    Borden, E.C.6    Garcia, J.7    Vogelbaum, M.A.8    Finke, J.9
  • 91
    • 80051944092 scopus 로고    scopus 로고
    • Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
    • 21723783
    • K.Wing, T.Yamaguchi, S.Sakaguchi. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends Immunol 2011; 32:428-33; PMID:21723783; http://dx.doi.org/10.1016/j.it.2011.06.002
    • (2011) Trends Immunol , vol.32 , pp. 428-433
    • Wing, K.1    Yamaguchi, T.2    Sakaguchi, S.3
  • 92
    • 84897374481 scopus 로고    scopus 로고
    • Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
    • 24657910
    • U.M.Litzenburger, C.A.Opitz, F.Sahm, K.J.Rauschenbach, S.Trump, M.Winter, M.Ott, K.Ochs, C.Lutz, X.Liu et al. Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR. Oncotarget 2014; 5:1038-51; PMID:24657910; http://dx.doi.org/10.18632/oncotarget.1637
    • (2014) Oncotarget , vol.5 , pp. 1038-1051
    • Litzenburger, U.M.1    Opitz, C.A.2    Sahm, F.3    Rauschenbach, K.J.4    Trump, S.5    Winter, M.6    Ott, M.7    Ochs, K.8    Lutz, C.9    Liu, X.10
  • 93
    • 84861589683 scopus 로고    scopus 로고
    • Recent developments on immunotherapy for brain cancer
    • 22533851
    • D.A.Wainwright, P.Nigam, B.Thaci, M.Dey, M.S.Lesniak. Recent developments on immunotherapy for brain cancer. Expert Opin Emerg Drugs 2012; 17(2):181-202; PMID:22533851; http://dx.doi.org/10.1517/14728214.2012.679929
    • (2012) Expert Opin Emerg Drugs , vol.17 , Issue.2 , pp. 181-202
    • Wainwright, D.A.1    Nigam, P.2    Thaci, B.3    Dey, M.4    Lesniak, M.S.5
  • 94
    • 79955591522 scopus 로고    scopus 로고
    • Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy
    • 21499132
    • C.E.Fadul, J.L.Fisher, T.H.Hampton, E.C.Lallana, Z.Li, J.Gui, Z.M.Szczepiorkowski, T.D.Tosteson, C.H.Rhodes, H.A.Wishart et al. Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy. J Immunother 2011; 34:382-9; PMID:21499132; http://dx.doi.org/10.1097/CJI.0b013e318215e300
    • (2011) J Immunother , vol.34 , pp. 382-389
    • Fadul, C.E.1    Fisher, J.L.2    Hampton, T.H.3    Lallana, E.C.4    Li, Z.5    Gui, J.6    Szczepiorkowski, Z.M.7    Tosteson, T.D.8    Rhodes, C.H.9    Wishart, H.A.10
  • 95
    • 77956061272 scopus 로고    scopus 로고
    • Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
    • 20146084
    • H.Ardon, S.Van Gool, I.S.Lopes, W.Maes, R.Sciot, G.Wilms, P.Demaerel, P.Bijttebier, L.Claes, J.Goffin et al. Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study. J Neurooncol 2010; 99:261-72; PMID:20146084; http://dx.doi.org/10.1007/s11060-010-0131-y
    • (2010) J Neurooncol , vol.99 , pp. 261-272
    • Ardon, H.1    Van Gool, S.2    Lopes, I.S.3    Maes, W.4    Sciot, R.5    Wilms, G.6    Demaerel, P.7    Bijttebier, P.8    Claes, L.9    Goffin, J.10
  • 98
    • 84871546020 scopus 로고    scopus 로고
    • α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
    • 23270484
    • Y.Akiyama, C.Oshita, A.Kume, A.Iizuka, H.Miyata, M.Komiyama, T.Ashizawa, M.Yagoto, Y.Abe, K.Mitsuya et al. α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial. BMC Cancer 2012; 12:623; PMID:23270484; http://dx.doi.org/10.1186/1471-2407-12-623
    • (2012) BMC Cancer , vol.12 , pp. 623
    • Akiyama, Y.1    Oshita, C.2    Kume, A.3    Iizuka, A.4    Miyata, H.5    Komiyama, M.6    Ashizawa, T.7    Yagoto, M.8    Abe, Y.9    Mitsuya, K.10
  • 99
    • 84925543609 scopus 로고    scopus 로고
    • Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    • 25366363
    • M.K.Hunn, E.Bauer, C.E.Wood, O.Gasser, M.Dzhelali, L.R.Ancelet, B.Mester, K.J.Sharples, M.P.Findlay, D.A.Hamilton et al. Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme. J Neurooncol 2015; 121:319-29; PMID:25366363; http://dx.doi.org/10.1007/s11060-014-1635-7
    • (2015) J Neurooncol , vol.121 , pp. 319-329
    • Hunn, M.K.1    Bauer, E.2    Wood, C.E.3    Gasser, O.4    Dzhelali, M.5    Ancelet, L.R.6    Mester, B.7    Sharples, K.J.8    Findlay, M.P.9    Hamilton, D.A.10
  • 100
    • 79960735609 scopus 로고    scopus 로고
    • A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
    • 21715171
    • C.N.Chang, Y.C.Huang, D.M.Yang, K.Kikuta, K.J.Wei, T.Kubota, W.K.Yang. A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma. J Clin Neurosci 2011; 18:1048-54; PMID:21715171; http://dx.doi.org/10.1016/j.jocn.2010.11.034
    • (2011) J Clin Neurosci , vol.18 , pp. 1048-1054
    • Chang, C.N.1    Huang, Y.C.2    Yang, D.M.3    Kikuta, K.4    Wei, K.J.5    Kubota, T.6    Yang, W.K.7
  • 101
    • 84864151615 scopus 로고    scopus 로고
    • Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial
    • 22120301
    • D.Y.Cho, W.K.Yang, H.C.Lee, D.M.Hsu, H.L.Lin, S.Z.Lin, C.C.Chen, H.J.Harn, C.L.Liu, W.Y.Lee et al. Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial. World Neurosurg 2012; 77:736-44; PMID:22120301; http://dx.doi.org/10.1016/j.wneu.2011.08.020
    • (2012) World Neurosurg , vol.77 , pp. 736-744
    • Cho, D.Y.1    Yang, W.K.2    Lee, H.C.3    Hsu, D.M.4    Lin, H.L.5    Lin, S.Z.6    Chen, C.C.7    Harn, H.J.8    Liu, C.L.9    Lee, W.Y.10
  • 102
    • 84857547272 scopus 로고    scopus 로고
    • A pilot study of IL-2Ralpha blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma
    • 22383993
    • J.H.Sampson, R.J.Schmittling, G.E.Archer,K.L.Congdon, S.K.Nair, E.A.Reap, A.Desjardins, A.H.Friedman, H.S.Friedman, J.E.Herndon2nd et al. A pilot study of IL-2Ralpha blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma. PLoS One 2012; 7:e31046; PMID:22383993; http://dx.doi.org/10.1371/journal.pone.0031046
    • (2012) PLoS One , vol.7 , pp. 31046
    • Sampson, J.H.1    Schmittling, R.J.2    Archer, G.E.3    Congdon, K.L.4    Nair, S.K.5    Reap, E.A.6    Desjardins, A.7    Friedman, A.H.8    Friedman, H.S.9    Herndon, J.E.10
  • 105
    • 84930416369 scopus 로고    scopus 로고
    • Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response
    • N.Hashimoto, A.Tsuboi, N.Kagawa, Y.Chiba, S.Izumoto, M.Kinoshita, N.Kijima, Y.Oka, S.Morimoto, H.Nakajima et al. Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response. Cancer Immunol Immunother 2015; 64(6):707-16; PMID:25772149; http://dx.doi.org/10.1007/s00262-015-1674-8
    • (2015) Cancer Immunol Immunother , vol.64 , Issue.6 , pp. 707-716
    • Hashimoto, N.1    Tsuboi, A.2    Kagawa, N.3    Chiba, Y.4    Izumoto, S.5    Kinoshita, M.6    Kijima, N.7    Oka, Y.8    Morimoto, S.9    Nakajima, H.10
  • 106
    • 80053061789 scopus 로고    scopus 로고
    • Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma
    • 21844505
    • E.A.Chiocca, L.K.Aguilar, S.D.Bell, B.Kaur, J.Hardcastle, R.Cavaliere, J.McGregor, S.Lo, A.Ray-Chaudhuri, A.Chakravarti et al. Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma. J Clin Oncol 2011; 29:3611-9; PMID:21844505; http://dx.doi.org/10.1200/JCO.2011.35.5222
    • (2011) J Clin Oncol , vol.29 , pp. 3611-3619
    • Chiocca, E.A.1    Aguilar, L.K.2    Bell, S.D.3    Kaur, B.4    Hardcastle, J.5    Cavaliere, R.6    McGregor, J.7    Lo, S.8    Ray-Chaudhuri, A.9    Chakravarti, A.10
  • 107
    • 84929044807 scopus 로고    scopus 로고
    • First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity
    • 25865468
    • V.E.Schijns, C.Pretto, L.Devillers, D.Pierre, F.M.Hofman, T.C.Chen, P.Mespouille, P.Hantos, P.Glorieux, D.A.Bota et al. First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity. Vaccine 2015; 33:2690-6; PMID:25865468; http://dx.doi.org/10.1016/j.vaccine.2015.03.095
    • (2015) Vaccine , vol.33 , pp. 2690-2696
    • Schijns, V.E.1    Pretto, C.2    Devillers, L.3    Pierre, D.4    Hofman, F.M.5    Chen, T.C.6    Mespouille, P.7    Hantos, P.8    Glorieux, P.9    Bota, D.A.10
  • 108
    • 79951962152 scopus 로고    scopus 로고
    • Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen–A24 with recurrent or progressive glioblastoma multiforme
    • 21149665
    • M.Terasaki, S.Shibui, Y.Narita, T.Fujimaki, T.Aoki, K.Kajiwara, Y.Sawamura, K.Kurisu, T.Mineta, F.Yamada et al. Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen–A24 with recurrent or progressive glioblastoma multiforme. J Clin Oncol 2011; 29:337-44; PMID:21149665; http://dx.doi.org/10.1200/JCO.2010.29.7499
    • (2011) J Clin Oncol , vol.29 , pp. 337-344
    • Terasaki, M.1    Shibui, S.2    Narita, Y.3    Fujimaki, T.4    Aoki, T.5    Kajiwara, K.6    Sawamura, Y.7    Kurisu, K.8    Mineta, T.9    Yamada, F.10
  • 109
    • 79961118475 scopus 로고    scopus 로고
    • Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma. Clinical article
    • 21568657
    • Y.Muragaki, T.Maruyama, H.Iseki, M.Tanaka, C.Shinohara, K.Takakura, K.Tsuboi, T.Yamamoto, A.Matsumura, M.Matsutani et al. Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma. Clinical article. J Neurosurg 2011; 115:248-55; PMID:21568657; http://dx.doi.org/10.3171/2011.4.JNS10377
    • (2011) J Neurosurg , vol.115 , pp. 248-255
    • Muragaki, Y.1    Maruyama, T.2    Iseki, H.3    Tanaka, M.4    Shinohara, C.5    Takakura, K.6    Tsuboi, K.7    Yamamoto, T.8    Matsumura, A.9    Matsutani, M.10
  • 110
    • 84907327423 scopus 로고    scopus 로고
    • Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
    • 24995786
    • E.Ishikawa, Y.Muragaki, T.Yamamoto, T.Maruyama, K.Tsuboi, S.Ikuta, K.Hashimoto, Y.Uemae, T.Ishihara, M.Matsuda et al. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma. J Neurosurg 2014; 121:543-53; PMID:24995786; http://dx.doi.org/10.3171/2014.5.JNS132392
    • (2014) J Neurosurg , vol.121 , pp. 543-553
    • Ishikawa, E.1    Muragaki, Y.2    Yamamoto, T.3    Maruyama, T.4    Tsuboi, K.5    Ikuta, S.6    Hashimoto, K.7    Uemae, Y.8    Ishihara, T.9    Matsuda, M.10

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.